DNS Management

• 

  Mr. Kenneth Dart

  President

• 

  Tim Tully, Ph.D.

  Executive Vice President of R&D & Chief Science Officer

• 

  Philip Perera M.D., MBA

  Vice President & Chief Medical Officer

• 

  Kenneth E. Johns, Jr., ESQ

  Chief Executive Officer & Chairman of the Board of Directors

• 

  Rod Scott, Ph.D.

  Vice President, Biology

• 

  David J. Carpenter, M.S., Pharm.D.

  Senior Director of Clinical Research and Development

• 

  Daniel Harvey, Ph.D.

  Chief Operating Officer

• 

  J. Guy Breitenbucher, Ph.D.

  Senior Director of Medicinal Chemistry

• 

  Joseph Djan, BSc., MBA

  Director of Clinical Operations

• 

  Ted St. Martin, CPA, MBA

  Chief Financial Officer

• 

  Kathleen Aertgeerts, Ph.D.

  Senior Director of Structural Biology

• 

  Kim Albizati

  Senior Director, Drug Product Development

• 

  Renu Menezes, MSHR, SHRM-SCP

  Senior Director of Human Resources

• 

  Brock Luty, Ph.D.

  Director of Scientific Computing

• 

  Anne Danks, Ph.D.

  Vice President of Preclinical Development

• 

  Bobbie Carter

  Director, Quality Assurance

• 

  Eben Massari

  Director, Leads Discovery

• 

  Kathe Stauber, Ph.D.

  Director of DMPK

• 

  Jim DeZazzo, Ph.D., Esq.

  Corporate IP Counsel

• 

• 

  Jef Vivian, Ph.D.

  Director of Pharmacology

• 

• 

• 

  Prasad Gullapalli, Ph.D.

  Director of Formulations

• 

• 

• 

  Alan Kaplan, Ph.D.

  Senior Director of CMC

• 

• 

• 

• 

•